Skip to main content

Survey seaking FDA approval for Pouchitis drug

ExeGi Pharma, the makers of the high potency probiotic Visbiome, are conducting a survey which is intended to help doctors better understand the personal experiences of those with a J-pouch who have experienced pouchitis or other problems associated with the J-pouch. Data from this survey will support ExeGi's efforts to develop a new live biotherapeutic agent intended for the prevention of pouchitis. This survey will take less than 10 minutes to complete.
Visbiome Survey

Original Post
Copyright © 2019 The J-Pouch Group. All rights reserved.
×
×
×
×